G2 Investment Partners Management’s Cardlytics CDLX Stock Holding History

G2 Investment Partners Management’s Portfolio CDLX Stock Details CDLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-12,813	Closed	-$311K	–	72
2025 Q3	$311K	Buy	+12,813	New	+$213K	0.06%	67
2021 Q3	–	Sell	-4,000	Closed	-$5.08M	–	78
2021 Q2	$5.08M	Buy	+4,000	New	+$4.51M	0.84%	40
2020 Q2	–	Sell	-7,046	Closed	-$2.46M	–	95
2020 Q1	$2.46M	Buy	+7,046	New	+$4.99M	0.81%	39
2019 Q2	–	Sell	-18,569	Closed	-$3.07M	–	62
2019 Q1	$3.07M	Buy	18,569 +13,862	+294%	+$2.25M	0.95%	34
2018 Q4	$510K	Buy	+4,707	New	+$794K	0.21%	55
2018 Q3	–	Sell	-18,594	Closed	-$4.05M	–	69
2018 Q2	$4.05M	Buy	+18,594	New	+$3.44M	1.34%	28

Other funds holding CDLX

CIP

CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

KGAMU

KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return

WPM

Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

G2 Investment Partners Management's CDLX Position: Q4 2025 in Review

G2 Investment Partners Management sold out of Cardlytics (CDLX) in Q4 2025, closing a stake of 12,813 shares — an estimated $311K sold.

G2 Investment Partners Management first reported a position in CDLX in Q2 2018 and held it in 6 quarters. The position peaked at $5.08M in Q2 2021. 70 funds tracked by Wall St. Rank hold CDLX as of Q4 2025.

G2 Investment Partners Management reported no remaining Cardlytics position as of Q4 2025 after selling out during the quarter.
G2 Investment Partners Management sold 12,813 Cardlytics shares in Q4 2025, an estimated $311K.
G2 Investment Partners Management first reported a position in Cardlytics in Q2 2018 and held it in 6 quarters.
G2 Investment Partners Management's Cardlytics position peaked at $5.08M in Q2 2021.
70 funds tracked by Wall St. Rank held Cardlytics as of Q4 2025.

Based on G2 Investment Partners Management's 13F filing for Q4 2025, filed 17 Feb 2026.